Ligand validation:2UV0

OHN: N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE

OHN is a Ligand Of Interest in 2UV0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2UV0_OHN_F_1169	83%	48%	0.069	0.925	0.6	1.38	-	3	0	0	100%	1
2UV0_OHN_H_1169	82%	56%	0.074	0.927	0.51	1.16	-	2	0	0	100%	1
2UV0_OHN_E_1169	74%	51%	0.087	0.916	0.58	1.3	-	3	0	0	100%	1
2UV0_OHN_G_1168	69%	57%	0.086	0.899	0.57	1.09	-	2	0	0	100%	1
3IX3_OHN_A_200	80%	65%	0.116	0.965	0.86	0.51	1	-	0	0	100%	1
4NG2_OHN_D_201	71%	32%	0.148	0.968	1.4	1.28	2	2	0	0	100%	1
3SZT_OHN_A_238	50%	42%	0.218	0.971	1.07	1.16	1	3	1	0	100%	1
8EY1_OHN_J_700	21%	1%	0.265	0.879	4.68	3.68	7	7	1	0	100%	1
6N9R_OHN_A_303	8%	20%	0.255	0.735	1.46	1.92	1	2	5	0	100%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.